Dermata Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
342
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
DRMA
Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-05-29 | English | |
| 8-K | 2026-05-27 | English | |
| S-3/A | 2026-05-22 | English | |
| ARS - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | |
| DEF 14A - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | |
| 4 - Dermata Therapeutics, Inc. (0001853816) (Issuer) | 2026-03-17 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47894784 | 424B3 | 2026-05-29 | English | ||
| 47845266 | 8-K | 2026-05-27 | English | ||
| 46861885 | S-3/A | 2026-05-22 | English | ||
| 34662829 | ARS - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | ||
| 34662700 | DEF 14A - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | ||
| 32968155 | 4 - Dermata Therapeutics, Inc. (0001853816) (Issuer) | 2026-03-17 | English | ||
| 32899840 | 8-K - DERMATA THERAPEUTICS, INC. (0001853816) (Filer) | 2026-02-25 | English | ||
| 32075223 | SCHEDULE 13G/A Filing | 2026-02-18 | English | ||
| 32075176 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 18542004 | SCHEDULE 13G/A - Dermata Therapeutics, Inc. (0001853816) (Subject) | 2026-02-09 | English | ||
| 32075231 | 8-K Filing | 2026-02-03 | English | ||
| 32075139 | SCHEDULE 13D/A Filing | 2026-02-02 | English | ||
| 32075157 | 424B3 Filing | 2026-01-29 | English | ||
| 13422563 | 424B5 | 2026-01-27 | English | ||
| 32075201 | 8-K Filing | 2026-01-27 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Dermata Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35467/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35467 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35467 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35467 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35467}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Dermata Therapeutics, Inc. (id: 35467)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.